A/RES/71/211 International cooperation to address and counter the world drug problem Substances: Guidance for Availability and Accessibility of Controlled Medicines”, and, for that purpose, to consider the provision of technical and financial assistance, upon request, to developing countries; 45. Urges all Member States to enact comprehensive measures aimed at stemming the abuse of prescription drugs, in particular through the establishment of awareness-raising initiatives targeting the general public and health -care providers; 46. Recognizes that it is necessary for Member States, under the three international drug control conventions and the fundamental principles of their domestic legal systems and national legislation, to consider, where appropriate: (a) Regularly reviewing and assessing their drug control policies, ensuring that they are effective, comprehensive, balanced and aimed at promoting the health and well-being of individuals, families, communities and society as a whole; (b) Providing, as appropriate, comprehensive, integrated drug demand reduction programmes, based on scientific evidence and covering a range of measures, including primary prevention, early intervention, treatment, care, rehabilitation, social reintegration and measures aimed a t minimizing the negative public health and social impacts of drug abuse, aimed at promoting health and social well-being among individuals, families and communities and reducing the adverse consequences of drug abuse for individuals and society as a whole; 47. Calls upon the United Nations Office on Drugs and Crime, the International Narcotics Control Board, the World Health Organization and other United Nations entities with pertinent technical and operational expertise, within their mandates, to continue to provide, upon request, advice and assistance to States that are reviewing and updating their drug policies, in compliance with the three international drug control conventions, taking into account their national priorities and needs through, among other things, the promotion of the exchange of information and best practices on scientific evidence-based policies adopted by States; 48. Calls upon Member States to promote and strengthen the exchange of information and, as appropriate, drug-related criminal intelligence among law enforcement and border control agencies, including through the United Nations Office on Drugs and Crime multilateral portals and regional information centres and networks, and to promote joint investigations and coordinate opera tions, in conformity with national legislation, and training programmes at all levels, in order to identify, disrupt and dismantle organized criminal groups operating transnationally that are involved in any activities related to the illicit production of and trafficking in narcotic drugs and psychotropic substances and the diversion of their precursors and related money-laundering; 49. Reiterates the commitment of Member States to share relevant information with, as appropriate, and strengthen the capaci ty of the World Health Organization, the United Nations Office on Drugs and Crime, the International Narcotics Control Board and other relevant international and regional organizations to prioritize the review of the most prevalent, persistent and harmful new psychoactive substances and to facilitate informed scheduling decisions by the Commission on Narcotic Drugs; 50. Encourages Member States to enhance the capacity of law enforcement agencies to detect and identify new psychoactive substances and amphe tamine-type stimulants, including methamphetamine, and promote cross-border cooperation and information-sharing to prevent their abuse and diversion, including through the use of existing International Narcotics Control Board and United Nations Office on Drugs and Crime tools and projects; 12/20